It should include the clinical reason for prescribing the compounded version, such as a drug shortage
Age is another important factorolder adults naturally experience sarcopenia (age-related muscle loss) and may be more vulnerable to further muscle decline during pharmacologically induced weight loss
The lack of body fat stores loss may be explained by the 18% increase in body fat mass associated with CHO supplementation alone, noted in the control group [6]
Weight loss effects are minimal In terms of weight loss, studies indicate that berberine has, at most, only a very limited effect, leading to a loss on the magnitude of five to 10 pounds, Ring says
Still, the FDA said that, Many of the adverse events reported for compounded products appear to be consistent with adverse events related to the FDA-approved versions of these products